Alexis Anne Thompson MD MPH
Pediatric Anemia and Red Blood Cell Hematology
Chief, Division of Hematology, Children's Hospital of Philadelphia, Professor in Pediatrics, University of Pennsylvania Perelman School of Medicine
Join to View Full Profile
3401 Civic Center BlvdPhiladelphia, PA 19104
Phone+1 215-590-2363
Dr. Thompson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Alexis Thompson is a pediatric hematologist/oncologist in Philadelphia, PA and is affiliated with the Children's Hospital of Philadelphia. She received her medical degree from Tulane University School of Medicine and has been in practice 34 years. She specializes in pediatric anemia and red blood cell hematology and is experienced in thalassemias, sickle-cell anemia, anemia, and sickle cell anemia. She has more than 150 publications and over 500 citings.
Education & Training
Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 1988 - 1990- Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 1987 - 1990
Children's Hospital Los AngelesResidency, Pediatrics, 1985 - 1986- Childrens Hospital Los AngelesInternship, Transitional Year, 1983 - 1984
Tulane University School of MedicineClass of 1983
Certifications & Licensure
CA State Medical License 1984 - Present
PA State Medical License 1987 - 2026
IL State Medical License 2001 - 2023
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia Start of enrollment: 1999 Jan 01
- Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment Start of enrollment: 2006 Feb 01
- Assessment of Pain in People With Thalassemia Start of enrollment: 2009 Mar 01
Publications & Presentations
PubMed
- ASH's commitment to SCD: building on 10 years of progress.Alexander A Boucher, Oladipo Bankole Cole, Payal C Desai, Chancellor Donald, Titilope A Fasipe
Blood Advances. 2026-03-10 - Accelerating novel therapies for sickle cell disease with RWE: ASH RC Data Hub as a strategically coordinated registry network.William A Wood, Osman N Yogurtcu, Emily Semmel, Kathleen Hewitt, Donna S Neuberg
Blood Advances. 2026-01-13 - Cortisol in sickle cell disease: a systematic review and meta-analysis.Kemar V Prussien, Margaret Mary Burke, Kandace Gollomp, Rosalind J Wright, Alexis A Thompson
Blood Advances. 2025-08-26
Abstracts/Posters
- Long-Term Clinical Outcomes of Lentiglobin Gene Therapy for Transfusion-Dependent _-Thalassemia in the Northstar (HGB-204) StudyAlexis A. Thompson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Resolution of Sickle Cell Disease Manifestations in Patients Treated with Lentiglobin Gene Therapy: Updated Results from the Phase 1/2 Hgb-206 Group C StudyAlexis A. Thompson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Pyruvate Kinase (PK) Protein and Enzyme Levels in the Diagnosis and Clinical Phenotype of PK DeficiencyAlexis A. Thompson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Northstar-2: Updated Safety and Efficacy Analysis of Lentiglobin Gene Therapy in Patients with Transfusion-Dependent _-Thalassemia and Non-_0/_0 Genotypes61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Friday Scientific Workshop on Novel Curative Options: Gene-Editing and Gene Therapy for Hemoglobinopathies with a Focus on Sickle Cell Disease61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Announcement of Awards: William Dameshek Prize and Henry M. Stratton Medal60th American Society of Hematology Annual Meeting - 12/4/2018
Press Mentions
Experts Advocate Adoption of Gene Therapy to Treat Sickle Cell in NigeriaJune 6th, 2025
Gene Therapy May Be a Game Changer for Transfusion-Dependent ThalassemiaFebruary 7th, 2025
Bluebird Bio to Present Additional Long-Term Follow-up Data from Gene Therapy Programs in Sickle Cell Disease and Beta-Thalassemia at the 66th American Society of Hematology (ASH) Annual Meeting and ExpositionNovember 5th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
